This project has successfully established National biobank consortium of Taiwan (NBCT) through the fund support and governance from the government. Currently NBCT already includes 37 biobanks and has more than 989 thousand participants. So far, NBCT already received 184 applications, including 32 from industries.One of them is an international collaboration project and application from Roche. The number of specimens in the NBCT is very large, coupled with large medical data, it is already Taiwan's largest biomedical industry resource.
Degradable Implantable Flexible Microelectrode Patch with High-Resolution Electrical Stimulation, Electrophysiological Signal Sensing, and Cellular Regenerative Therapy
The Application of Multi-Functional Graphene-Based Materials in Targeti ng Detection, Diagnosis and Therapy
The establishment of National Biobank Consortium of Taiwan (NBCT)
Development of novel cannabinoid CB1receptor antagonists with high oral absorption and no central adverse effects for the treatment of cardiovascular diseases
Technology maturity：Trial production
Exhibiting purpose：Display of scientific results
Trading preferences：Negotiate by self
Coming soon!